Defunct Company
Total Trials
6
As Lead Sponsor
2
As Collaborator
4
Total Enrollment
916
NCT00596583
DY001: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery
Phase: Phase 3
Role: Lead Sponsor
Start: Apr 30, 2007
Completion: May 31, 2008
NCT00596492
DY002: Safety and Effectiveness of DYME as an Agent for Selective Staining of the Anterior Capsule During Cataract Surgery
Start: May 31, 2008
Completion: Dec 31, 2008
NCT01943045
Phase 2 Study of NGM282 in Patients With Type 2 Diabetes
Phase: Phase 2
Role: Collaborator
Start: Sep 30, 2013
Completion: Sep 30, 2014
NCT02026401
Phase 2 Study of NGM282 in Patients With Primary Biliary Cirrhosis
Start: Feb 28, 2014
Completion: Dec 31, 2014
NCT02135536
Phase 2b Study of NGM282 Extended Treatment in Patients With Primary Biliary Cirrhosis
Start: May 31, 2014
Completion: Feb 29, 2016
NCT02443116
Study of NGM282 in Patients With Nonalcoholic Steatohepatitis (NASH)
Start: Jul 31, 2015
Completion: Jan 17, 2020